Skip to main content
. 2018 Jan 14;84(3):568–578. doi: 10.1111/bcp.13481

Table 1.

Maternal characteristics. Metformin study from European Teratology Information Services (TIS) 1993–2015

Characteristics Metformin group (n = 458) Reference group (n = 479)
Maternal age (yr) median (IQR) 35 (31–39) 35 (31–38)
Body mass index (BMI) n (%)
Missing 226 (49) 310 (65)
BMI ≤ 30 126 (28) 152 (32)
BMI > 30 106 (23) 17 (4)
Comorbidities and co‐medication n (%)
≥ 1 comorbidities (except diabetes) 178 (39) 114 (24)
Pre‐gestational diabetes 261 (57) 2 (0.4)
Hypertension 60 (13) 8 (2)
Psychiatric disorders 20 (4) 34 (7)
Polycystic ovary syndrome 25 (5) 1 (0.2)
Hyperlipidaemia 21 (5) 2 (0.4)
Any concomitant medication 352 (77) 212 (44)
Other oral antidiabetic drugs 106 (23) 0 (0)
Insulin 123 (27) 0 (0)
Gestational age at first contact
Median (IQR) [wk] 9 (6–13.5) 8 (6–14)
Smoking n (%)
Missing 124 (27) 142 (30)
No 285 (62) 298 (62)
≤5 cigarettes/day 11 (2) 16 (3)
>5 cigarettes/day 38 (8) 23 (5)
Alcohol n (%)
Missing 146 (32) 167 (34)
<1 drink/day 295 (64) 285 (60)
≥1 drink/day 17 (4) 27 (6)
Folic acid n (%)
Missing 230 (50) 259 (54)
Yes 173 (38) 198 (41)
No 55 (12) 22 (5)
Previous pregnancies and deliveries n (%)
Missing 33 (7) 41 (9)
Primigravida 119 (26) 167 (35)
Primiparous 115 (25) 116 (24)
Multiparous 154 (33) 104 (22)
Previous SABs n (%)
Missing 70 (15) 92 (19)
0 287 (63) 313 (65)
1 64 (14) 57 (12)
≥2 37 (8) 17 (4)
Previous children with birth defects n (%)
Missing 228 (50) 243 (51)
Yes 11 (2) 9 (2)
No 219 (48) 227 (47)

IQR, interquartile range; SAB, spontaneous abortion